Hypothalamic-Pituitary-Adrenal Axis Effects on Innate and Adaptive Immunity

[1]  E. Sternberg,et al.  Neuroendocrine regulation of immunity. , 2003, Annual review of immunology.

[2]  D. Franchimont,et al.  Glucocorticoids and Inflammation Revisited: The State of the Art , 2003, Neuroimmunomodulation.

[3]  V. Vicennati,et al.  Hormonal regulation of interleukin-6 production in human adipocytes , 2002, International Journal of Obesity.

[4]  S. Rivest.  How circulating cytokines trigger the neural circuits that control the hypothalamic–pituitary–adrenal axis , 2001, Psychoneuroendocrinology.

[5]  N. Rothwell,et al.  Cytokines and acute neurodegeneration , 2001, Nature Reviews Neuroscience.

[6]  D. Xia,et al.  Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. , 2001, Immunology letters.

[7]  M. Delgado,et al.  Inhibitory neuropeptide receptors on macrophages. , 2001, Microbes and infection.

[8]  L. Muglia,et al.  Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Chrousos,et al.  Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease , 1999, Trends in Endocrinology & Metabolism.

[10]  R. Seder,et al.  Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. , 1998, Journal of immunology.

[11]  D. Postma,et al.  Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. , 1998, American journal of respiratory cell and molecular biology.

[12]  M. Girndt,et al.  Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes. , 1998, Transplantation.

[13]  D. Torpy,et al.  Corticotropin‐Releasing Hormone and Inflammation , 1998, Annals of the New York Academy of Sciences.

[14]  D. Umetsu,et al.  Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. , 1998, Journal of immunology.

[15]  P. Sawchenko,et al.  Evidence for an Intramedullary Prostaglandin-Dependent Mechanism in the Activation of Stress-Related Neuroendocrine Circuitry by Intravenous Interleukin-1 , 1997, The Journal of Neuroscience.

[16]  D. Umetsu,et al.  Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. , 1997, Journal of immunology.

[17]  D. Kasprowicz,et al.  Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. , 1997, Journal of immunology.

[18]  G. Chrousos,et al.  In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. , 1996, Endocrinology.

[19]  T. van der Poll,et al.  Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.

[20]  C. Stein,et al.  Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Mason,et al.  Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. , 1996, Journal of immunology.

[22]  T. Mosmann,et al.  The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.

[23]  G. Chrousos,et al.  Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. , 1995, Endocrinology.

[24]  G. Chrousos,et al.  Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. , 1995, Gut.

[25]  G. Chrousos,et al.  Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents. , 1995, Endocrinology.

[26]  G. Chrousos,et al.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.

[27]  D. Boumpas,et al.  Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates , 1993, Annals of Internal Medicine.

[28]  E. Remmers,et al.  Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. , 1993, Journal of immunology.

[29]  F. Aloisi,et al.  Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: Synergism with IL-1β and TNFα , 1993, Journal of Neuroimmunology.

[30]  E. Benveniste,et al.  Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine , 1993, Journal of Neuroimmunology.

[31]  G. Chrousos,et al.  Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. , 1992, The Journal of clinical investigation.

[32]  S. Genedani,et al.  Influence of CRF and α-MSH on the migration of human monocytes in vitro , 1992, Neuropeptides.

[33]  J. Norton,et al.  Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery. , 1992, Metabolism: clinical and experimental.

[34]  G. Mazzocchi,et al.  Direct secretagogue effect of corticotropin-releasing factor on the rat adrenal cortex: the involvement of the zona medullaris. , 1992, Endocrinology.

[35]  G. Chrousos,et al.  The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.

[36]  G. Chrousos,et al.  Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. , 1991, Science.

[37]  R. Jain,et al.  Receptor-mediated immunomodulation by corticotropin-releasing factor. , 1991, Cellular immunology.

[38]  J. Herbert,et al.  The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat , 1990, Regulatory Peptides.

[39]  J. Saydoff,et al.  Effects of immunoneutralization of corticotropin-releasing hormone on ultradian rhythms of plasma adrenocorticotropin. , 1990, Endocrinology.

[40]  M. Whitnall.  Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons. , 1989, Neuroendocrinology.

[41]  A. Herz,et al.  A two-step mechanism by which corticotropin-releasing hormone releases hypothalamic beta-endorphin: the role of vasopressin and G-proteins. , 1989, Endocrinology.

[42]  Vijendra K. Singh,et al.  Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression , 1989, Journal of Neuroimmunology.

[43]  C. Turck,et al.  Stimulation of rat B‐lymphocyte proliferation by corticotropin‐releasing factor , 1989, Journal of neuroscience research.

[44]  V. Singh,et al.  Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease. , 1988, Immunology letters.

[45]  C. Oliver,et al.  Evidence for basal and stress-induced release of corticotropin releasing factor in the push-pull cannulated median eminence of conscious free-moving rats , 1987, Neuroscience Letters.

[46]  G. Chrousos,et al.  The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man. , 1987, The Journal of clinical endocrinology and metabolism.

[47]  B. Beutler,et al.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.

[48]  G. Chrousos,et al.  Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey , 1986, Peptides.

[49]  M. Nicholls,et al.  Spontaneous and stimulated adrenocorticotropin and vasopressin pulsatile secretion in the pituitary venous effluent of the horse. , 1986, Endocrinology.

[50]  K. Catt,et al.  Magnocellular axons in passage through the median eminence release vasopressin , 1986, Nature.

[51]  G. Chrousos,et al.  Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system , 1986, Nature.

[52]  D. Jacobowitz,et al.  Corticotropin releasing factor-like immunoreactivity in sensory ganglia and capsaicin sensitive neurons of the rat central nervous system: Colocalization with other neuropeptides , 1985, Peptides.

[53]  G. Chrousos,et al.  Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. , 1984, The Journal of clinical endocrinology and metabolism.

[54]  T. Suda,et al.  Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues. , 1984, The Journal of clinical endocrinology and metabolism.

[55]  S. Lamberts,et al.  Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. , 1984, The Journal of clinical endocrinology and metabolism.

[56]  I. Merchenthaler,et al.  Immunocytochemical localization of corticotropin releasing factor (CRF) in the rat spinal cord , 1983, Brain Research.

[57]  J. Ottenweller,et al.  Adrenal innervation may be an extrapituitary mechanism able to regulate adrenocortical rhythmicity in rats. , 1982, Endocrinology.

[58]  S. Reichlin.  Neuroendocrinology of infection and the innate immune system. , 1999, Recent progress in hormone research.

[59]  G. Trinchieri,et al.  Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12. , 1997, The Journal of investigative dermatology.

[60]  Y. Kotake,et al.  Corticotropin-releasing hormone enhances the superoxide anion production of rabbit peritoneal macrophages stimulated with N-formyl-methionyl-leucyl-phenylalanine. , 1994, Life sciences.

[61]  C. Franceschi,et al.  Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. , 1993, Life sciences.

[62]  J. Hinson.  Paracrine control of adrenocortical function: a new role for the medulla? , 1990, The Journal of endocrinology.

[63]  J W Funder,et al.  Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia. , 1989, Neuroendocrinology.

[64]  Phillips Mi.  Functions of Angiotensin in the Central Nervous System , 1987 .

[65]  G. Chrousos,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society Corticotropin-Releasing Hormone Induces Skin Mast Cell Degranulation and Increased Vascular Permeability, A Possible Explanation for Its Proinflammatory Effects* , 2022 .